II. Indications
- 
                          Human Immunodeficiency Virus (HIV)
- Pneumocystis carinii Pneumonia prophylaxis
 - Pneumocystis carinii Pneumonia treatment
- Patients unable to tolerate Bactrim
 
 
 - Babesiosis (off-label)
 - Toxoplasmosis in HIV Infection (off-label)
 
III. Contraindications
- Creatinine Clearance <30 ml/minute/1.73m2
 - Breast Feeding of infants under 11 lb (5 kg)
 
IV. Mechanism
- Synthetic hydroxynaphthoquinone with Antiprotozoal activity
 - Atovaquone blocks mitochondrial electron transport at complex 3 of the respiratory chain of Protozoa
- Inhibits Pyrimidine synthesis (and therefore Protozoal DNA synthesis)
 
 
V. Dosing: Pneumocystis carinii Pneumonia
- Adults (and children age >13 years)
- Prophylaxis: 1500 mg orally daily with food
 - Treatment: 750 mg orally twice daily with food for 21 days
 
 
VI. Dosing: Toxoplasmosis in comorbid HIV Infection
- Atovaquone is taken in combination with either Sulfadiazine or pyrimethanine-leucovorin
 - Adults (off-label)
- Acute: 1500 mg orally twice daily with food for 6 weeks or more
 - Chronic: 750 to 1500 mg orally with food twice daily
 
 
VII. Dosing: Babesiosis (Mild to Moderate Disease, Off-Label Use)
- Taken in combination with Azithromycin (high dose Azithromycin if Immunocompromised)
 - Adult: 750 mg orally every 12 hours with food
 - Child: 20 mg/kg (up to 750 mg) orally every 12 hours with food for 7 to 10 days
 
VIII. Dosing: Malaria
- See Atovaquone/Proguanil (Malarone)
 
IX. Precautions: Poor absorption
- Take with food (fatty meal) to ensure absorption
 - Up to 10% of patients still may not absorb Mepron
 - Repeat dose if Vomiting occurs within one hour of treatment in adults (within 30 minutes for children)
 - Tablets may be crushed and mixed with 10 ml water if unable to swallow tablets
 
X. Efficacy: HIV
XI. Adverse Effects
- Less dose-limiting adverse reactions than Bactrim
- Atovaquone: 7%
 - Bactrim: 20%
 
 - Rash
 - Abdominal Pain
 - Nausea or Vomiting
 - Diarrhea
 - Headache
 - Mild Liver Function Test abnormalities
 
XII. Safety
- Pregnancy Category C
 - Unknown safety in Lactation
- Contraindicated in Breast Feeding of infants under 11 lb (5 kg)
 
 
XIII. Drug Interactions
- Reduced plasma levels of Atovaquone (and decreased efficacy)
- Efavirenz (avoid)
 - Rifampin (avoid)
 - Rifabutin
 - Rifapentine
 - Tetracycline
 - Metoclopramide (Reglan)
 
 
XIV. Resources
- Atovaquone Suspension (DailyMed)
 
XV. References
Images: Related links to external sites (from Bing)
Related Studies
| atovaquone (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| ATOVAQUONE 750 MG/5 ML SUSP | Generic | $1.22 per ml | 
| ATOVAQUONE-PROGUANIL 250-100 MG TABLET | Generic | $2.03 each | 
| ATOVAQUONE-PROGUANIL 62.5-25 | Generic | $0.63 each |